Our result revealed that the serum level of RBP4 was significantly higher in patients with ER or PR negative than those with ER or PR positive, which indicated that high serum RBP4 levels could be a risk factor for poor prognosis of breast cancer. Here, ESR1 is linked to breast cancer.